Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.8265
-0.0084-1.01%
Post-market: 0.85000.0235+2.84%19:40 EDT
Volume:277.22K
Turnover:226.57K
Market Cap:27.43M
PE:-0.33
High:0.8690
Open:0.8444
Low:0.7895
Close:0.8349
Loading ...
Mar 09, 2020

Major Issues Report

Current report, items 1.01, 5.07, and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Dec 26, 2019

Major Issues Report

Current report, items 5.02, 5.03, 8.01, and 9.01
Dec 16, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 06, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Dec 03, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 31, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 30, 2019

Correspondence

[Cover]Correspondence
Oct 28, 2019

Correspondence

[Cover]Correspondence
Oct 21, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Oct 21, 2019

Correspondence

[Cover]Correspondence
Oct 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 17, 2019

Correspondence

[Cover]Correspondence
Oct 17, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Oct 11, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Oct 11, 2019

Correspondence

[Cover]Correspondence
Oct 01, 2019

Major Issues Report

Current report, items 8.01 and 9.01